News

Meis1 – new insights into restless legs syndrome

21.03.2014 | The restless legs syndrome (RLS) is a neurological disorder which is characterized by an urge to...

Influence of genetic background in hepatosteatosis

14.03.2014 | A number of studies carried out over the recent years in populations with different ethnic...

Accurate Huntington’s disease model reveals early phenotypes

14.02.2014 | Huntington’s disease (HD) is an autosomal dominantly inherited neurodegenerative disorder...

Phenotype your mouse model

GMC I: 

  1. Systemic, comprehensive phenotyping in 14 different disease areas
  2. Customized primary phenotypic screening in specific areas of interest (e.g. behavior, neurology and neuropathology)

GMC II: 

  1. Hypothesis-driven phenotypic analysis using environmental challenges
  2. Combining environmental challenges

GMCIII:

  1. Systemic analysis of compounds and drugs

Collaborators in primary screening per country

Director

Prof. Dr. Martin Hrabě de Angelis

View results of mutant lines

View the results of mutant mouse lines in the GMC phenomap.

IMPC - Intl Mouse Phenotyping Consortium

How primary mouse phenotyping leads to novel insights for human health

Mouse phenotyping helps to better understand human diseases. Here we present an example how systemic primary screening of mouse mutants uncovers unexpected new gene functions.  Read more...

The GMC Consortium:

We are partners in: